Aurinia Pharmaceuticals
AUPH
#4837
Rank
โ‚น189.27 B
Marketcap
โ‚น1,472
Share price
-3.54%
Change (1 day)
113.30%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2026 (TTM): โ‚น12.43 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น0.29 Billion. In 2025 the company made an earning of โ‚น11.41 Billion, an increase over its 2024 earnings that were of โ‚น1.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น12.43 B8.92%
2025 โ‚น11.41 B864.64%
2024 โ‚น1.18 B-116.44%
2023 -โ‚น7.2 Billion-31.8%
2022 -โ‚น10.55 Billion-39.4%
2021 -โ‚น17.41 Billion61.9%
2020 -โ‚น10.76 Billion-9.73%
2019 -โ‚น11.92 Billion92.65%
2018 -โ‚น6.19 Billion36.39%
2017 -โ‚น4.54 Billion106.29%
2016 -โ‚น2.2 Billion-15.4%
2015 -โ‚น2.6 Billion65.84%
2014 -โ‚น1.57 Billion129.82%
2013 -โ‚น0.69 Billion-26.6%
2012 -โ‚น0.93 Billion
2010 -โ‚น0.53 Billion-39.22%
2009 -โ‚น0.87 Billion-43.78%
2008 -โ‚น1.54 Billion-53.19%
2007 -โ‚น3.29 Billion42.97%
2006 -โ‚น2.3 Billion-23.03%
2005 -โ‚น2.99 Billion36.1%
2004 -โ‚น2.2 Billion172.57%
2003 -โ‚น0.81 Billion484.61%
2002 -โ‚น0.14 Billion
2000 -โ‚น0.66 Billion453.81%
1999 -โ‚น0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
โ‚น496.71 B 3,636.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-โ‚น2.14 Billion-116.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-โ‚น0.53 Billion-103.97%๐Ÿ‡บ๐Ÿ‡ธ USA